Author

Kailee A. Rutherford

University of California, Los AngelesORCID 0009-0001-2575-5771Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alice SoragniiD· 1 shared Anand VaidyaiD· 1 shared Andreanne SannajustiD· 1 shared Arthur S. TischleriD· 1 shared Bethany N. LandryiD· 1 shared Camilo JiméneziD· 1 shared Cynthia M. Estrada-ZunigaiD· 1 shared Gail Elizabeth TomlinsoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice SoragniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Patient-derived organoids reveal hypoxia-driven plasticity and therapeutic vulnerabilities in pheochromocytomas and paragangliomas

Xiaojing Wang, Maite Calucho, Cynthia M. Estrada-Zuniga, Misbah Noureen, Hector Gonzalez‐Cantu, Samantha Mossuto, Jonathan N. Levi, Bethany N. Landry, Qianjin Guo, Kailee A. Rutherford, Zi-Ming Cheng, Andreanne Sannajust, Sapna Raghunathan, Sanskriti Balaji, Viviane Nascimento Da Conceicao, , Patricia L. M. Dahia

This study uses patient-derived organoids to model pheochromocytomas and paragangliomas, revealing hypoxia-driven plasticity and therapeutic vulnerabilities, including responses to abemaciclib.

bioRxiv · Aug 22, 2025 · PreprintCancer Biology